During its 11-year existence, The ASCO Cancer Foundation has
been vital to ASCO programs, providing support that would not be
possible through member dues only-more than $10 million in
2009 alone. During that time, the Foundation has continued to
evolve from the charitable arm of its parent society, ASCO, to an
increasingly high-profile philanthropic foundation. Beginning in
2011, the Foundation will be known by a new name that reflects that
evolution: the Conquer Cancer Foundation of the American Society of
Clinical Oncology.
The name Conquer Cancer Foundation inspires confidence and makes
its mission instantly comprehensible to the general public and
donors. Along with the name change, the Foundation has updated its
mission and vision statements. Its mission: to conquer cancer
worldwide by funding breakthrough research and sharing cutting-edge
knowledge. Its vision: a world free from the fear of cancer.
"Conquer Cancer Foundation is more than a name. It
reinforces our individual and collective consecration to our
mission. It creates our invitation to all who will partner with us
as we seek to fulfill our Foundation's new name and our abiding
mission…the mission to conquer cancer."
-Martin Murphy, Jr, PhD, DMedSc, Chair, Conquer Cancer
Foundation
Although ASCO is well known among oncology professionals, the
public at large is not necessarily familiar with the Society or
with clinical oncology. While ASCO continues to provide resources
to its members, the Conquer Cancer Foundation reaches beyond the
membership, to individuals and organizations of all types, for
support. The new name distinguishes the Foundation as a separate
organization and establishes a differentiated mission that
audiences will find relevant and care about, while remaining
closely tied to ASCO.
Critical Support for a Broad Range of
Programs
"ASCO has the
expertise and competency to deliver a tremendous array of programs
to both our members and the public. What transforms these ideas
into reality is financial support, and that must come from sources
beyond ASCO membership dues."
-Allen S. Lichter, MD, ASCO CEO
The Foundation seeks support for programs including Annual
Meeting educational tracks, enduring materials, thematic symposia,
Virtual Meetings, and online Abstracts. It helps support ASCO's
award-winning patient education website, Cancer.Net, which provides
timely, oncologist-approved information to patients and their
families. Its reach extends from the grassroots level, through
support of the State Affiliate Program, to across international
borders, through the Advanced Cancer Courses and the Long-term
International Fellowship program.
Much of the Foundation's fundraising has focused on its Grants
and Awards Program. Established by ASCO in 1983, the Grants Program
awarded its first Young Investigator Award in 1984. In 1992, the
program was expanded to include the Career Development Award, and
now, the Grants program offers funding to every level of
physician-scientist, both in the United States and throughout the
world. To date, more than $66 million in research grants have
been awarded to more than 800 investigators.
Along with research grants, the Foundation administers a robust
Awards Program designed to recognize and promote the career
development of high-quality clinicians and researchers. More than
$1 million has been awarded to researchers through the
International Development and Education Award (IDEA), Clinical
Trials Participation Award (CTPA), and Merit Award. Established in
2009, the ASCO Diversity in Oncology Initiative, funded by Susan G.
Komen for the Cure®, has provided support for three additional
award programs: the Loan Repayment Program, Medical Student
Rotation Program, and Resident Travel Award.
Collaborating for Success
Given that treating cancer requires a collaborative relationship
among a multidisciplinary team of caregivers, funding cancer
research and education programs also benefits from a collaborative
approach. To this end, the Foundation has broken new ground in
developing relationships with like-minded organizations. A
first-of-its-kind collaboration with Susan G. Komen for the Cure
was formed in 2008, when the Foundation received $10 million
from Komen for the Cure to develop programs focused on access to,
quality of, and delivery of cancer care. Through this relationship,
ASCO and the Foundation have created several important initiatives,
among them the Diversity in Oncology Initiative, designed to
facilitate the recruitment and retention of individuals from
populations underrepresented in medicine to cancer careers, and the
Improving Cancer Care Grant, the largest-ever grant offered by the
Foundation, at $1.35 million.
"The collaborative relationship with Komen was new territory
for the Foundation. Now, more than 2 years later, both
organizations are thrilled with how productive and fruitful it has
been. Not only do we look forward to continuing our association
with Komen, we look forward to building similar relationships with
other organizations, all with the objective of benefitting people
living with cancer."
-Nancy R. Daly, MS, MPH, Executive Director, Conquer Cancer
Foundation
Building Personal and Public Support
Recognizing the need to both increase efforts and ensure its
longevity, the Foundation in 2008 established its Mission
Endowment. The Endowment represents an opportunity for corporations
and individuals to invest in the Foundation's critical mission
areas: research, professional education, patient and family
support, international outreach, and access to care. The Mission
Endowment is an investment in the future of the practice of
oncology, for the benefit of patients.
The Foundation continues to seek innovative ways to spread its
message and bring notice to the work it does. In 2010, the
Foundation launched a new Annual Giving Campaign, Leadership to
Legacy, which supports the Foundation's Research Grants Program.
This campaign is an opportunity for ASCO members and other oncology
professionals to support the next generation of researchers.
Leadership of ASCO and the Foundation, and ASCO members and
nonmembers alike, have risen to this challenge, and thus far,
Leadership to Legacy has raised sufficient funds to support a Young
Investigator Award.
The Conquer Cancer Foundation moves into its second decade with
not just a new name, but also a renewed sense of direction and
purpose. Through comprehensive marketing and communications plans
and its new consumer-friendly brand, the Foundation hopes to reach
new audiences outside the traditional cancer community, acquiring
new friends while renewing the support of existing donors. Through
this outreach, the Foundation will be able to expand its portfolio
of programs benefitting people living with cancer and the people
who care for and about them.
Visit ConquerCancerFoundation.org to learn about the programs we
support, apply for grants and awards, or make a gift. ■
© 2011. American Society of Clinical Oncology. All rights
reserved.